TPD52 and cancer: In addition, studies have shown that targeting Cdc20 may be an effective therapeutic approach for cancer.[32, 38] Structural studies have shown that Cdc20 can selectively bind to TPD52 by recognizing the D‐box motif (40RRELAKVEE48 in humans).